Low-frequency ultrasound irradiation increases paclitaxel-induced sarcoma cells apoptosis and facilitates the transmembrane delivery of drugs

Sarcoma is a malignant tumor derived from interstitial tissues and requires comprehensive treatment including chemotherapy. Paclitaxel (PTX) is an active agent against sarcoma, but its effect is not sufficiently acceptable and needs to be improved. Low-frequency ultrasound (LFU) has been documented...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tana, Zhang, Yixuan, Wang, Tan, Li, Mo, Zhang, Ying, Zhao, Dan, Xu, Libin, Wang, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792775/
https://www.ncbi.nlm.nih.gov/pubmed/36582521
http://dx.doi.org/10.3389/fphar.2022.1065289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792775/
https://www.ncbi.nlm.nih.gov/pubmed/36582521
http://dx.doi.org/10.3389/fphar.2022.1065289

Ejemplares similares